The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A prospective study evaluating ECG changes in pediatric patients taking ziprasidone for TD, OCD, or a pervasive developmental disorder reported a mean increase in the QTc interval from baseline to peak of 28 Æ 26 milliseconds”
From Practice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders (2013) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Children's Yale-Brown Obsessive Compulsive Scale: Reliability and Validity
SCAHILL, L., RIDDLE, M. A., McSWIGGIN-HARDIN, M., ORT, S. I., KING, R. A., GOODMAN, W. K., CICCHETTI, D., & LECKMAN, J. F. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199706000-00023 · Cited by 2,045
Self-citationA placebo-controlled trial of risperidone in Tourette syndrome
Scahill, L., Leckman, J. F., Schultz, R. T., Katsovich, L., & Peterson, B. S. (2003) · Neurology · doi:10.1212/01.wnl.0000055434.39968.67 · Cited by 362
Self-citation
Research works printed but not linked: 38
- Algra, 1993, QT interval variables from 24 hour electrocardiography and the two year risk of sudden death, Br Heart J, 70, 43, 10.1136/hrt.70.1.43 · DOI · Paper page
- Al-Khatib, 2003, What clinicians should know about the QT interval, JAMA, 289, 2120, 10.1001/jama.289.16.2120 · DOI · Paper page
- Aman, 1987, The aberrant behavior checklist: factor structure and the effect of subject variables in American and New Zealand facilities, Am J Ment Defic, 91, 570
- Anderson, 2002, Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management, Am Heart J, 144, 769, 10.1067/mhj.2002.125804 · DOI
- Arato, 2002, A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160 mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study, Int Clin Psychopharmacol, 17, 207, 10.1097/00004850-200209000-00001 · DOI · Paper page
- Bazett, 1918, An analysis of the time-relations of electrocardiograms, Heart, 7, 353
- Bednar, 2001, The QT interval, Prog Cardiovasc Dis, 43, 1
- Blair, 2004, Electrocardiographic safety profile and monitoring guidelines in pediatric psychopharmacology, J Neural Transm, 111, 791, 10.1007/s00702-004-0153-8 · DOI
- Daniel, 1999, Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group, Neuropsychopharmacology, 20, 491, 10.1016/S0893-133X(98)00090-6 · DOI · Paper page
- Desta, 1999, Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6), Clin Pharmacol Ther, 65, 10, 10.1016/S0009-9236(99)70117-7 · DOI
- Flockhart, 2000, Studies on the mechanism of a fatal clarithromycin-pimozide interaction in a patient with Tourette syndrome, J Clin Psychopharmacol, 20, 317, 10.1097/00004714-200006000-00005 · DOI
- Fulop, 1987, ECG changes during haloperidol and pimozide treatment of Tourette's disorder, Am J Psychiatry, 144, 673, 10.1176/ajp.144.5.673 · DOI
- Garson, 1993, How to measure the QT interval-what is normal?, Am J Cardiol, 72, 14B, 10.1016/0002-9149(93)90034-A · DOI · Paper page
- Gutgesell, 1999, AHA scientific statement: cardiovascular monitoring of children and adolescents receiving psychotropic drugs, J Am Acad Child Adolesc Psychiatry, 38, 1047, 10.1097/00004583-199908000-00022 · DOI
- Honig, 1992, Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin, Clin Pharmacol Ther, 52, 231, 10.1038/clpt.1992.135 · DOI · Paper page
- Jurima-Romet, 1994, Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals, Drug Metab Dispos, 22, 849
- Kautzner, 2002, QT interval measurements, Card Electrophysiol Rev, 6, 273, 10.1023/A:1016389227576 · doi:10.1023/a:1016389227576
- Keck, 2001, Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double-blind, placebo-controlled, multicenter studies, J Clin Psychopharmacol, 21, 27, 10.1097/00004714-200102000-00007 · DOI
- Keck, 2003, Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial, Am J Psychiatry, 160, 741, 10.1176/appi.ajp.160.4.741 · DOI · Paper page
- Labellarte, 2003, The relevance of prolonged QTc measurement to pediatric psychopharmacology, J Am Acad Child Adolesc Psychiatry, 42, 642, 10.1097/01.CHI.0000046860.56865.25 · doi:10.1097/01.chi.0000046860.56865.25
- Leckman, 1989, The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
- Malik, 2001, Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling, Drug Saf, 24, 323, 10.2165/00002018-200124050-00001 · DOI · Paper page
- McDougle, 2002, Case series: use of ziprasidone for maladaptive symptoms in youths with autism, J Am Acad Child Adolesc Psychiatry, 41, 921, 10.1097/00004583-200208000-00010 · DOI · Paper page
- Miller, 2001, Diagnostic accuracy of screening electrocardiograms in long QT syndrome I, Pediatrics, 108, 8, 10.1542/peds.108.1.8 · DOI
- Morganroth, 1991, Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia, Am J Cardiol, 67, 774, 10.1016/0002-9149(91)90541-R · DOI · Paper page
- Moss, 1993, Measurement of the QT interval and the risk associated with QTc interval prolongation: a review, Am J Cardiol, 72, 23B, 10.1016/0002-9149(93)90036-C · DOI · Paper page
- Moss, 1982, Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias, Mod Concepts Cardiovasc Dis, 51, 85
- Patel, 2002, Experience with ziprasidone, J Am Acad Child Adolesc Psychiatry, 41, 495, 10.1097/00004583-200205000-00003 · doi:10.1097/00004583-200205000-00003
- Pezawas, 2000, Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance, Int Clin Psychopharmacol, 15, 207, 10.1097/00004850-200015040-00003 · DOI
- Priori, 2003, Risk stratification in the long-QT syndrome, N Engl J Med, 348, 1866, 10.1056/NEJMoa022147 · DOI · Paper page
- Rautaharju, 1992, Sex differences in the evolution of the electrocardiographic QT interval with age, Can J Cardiol, 8, 690
- Reilly, 2000, QTc-interval abnormalities and psychotropic drug therapy in patients, Lancet, 355, 1048, 10.1016/S0140-6736(00)02035-3 · DOI · Paper page
- Sallee, 2000, Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study, J Am Acad Child Adolesc Psychiatry, 39, 292, 10.1097/00004583-200003000-00010 · DOI · Paper page
- Scahill, 2001, Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism, J Child Adolesc Psychopharmacol, 11, 377, 10.1089/104454601317261555 · DOI
- Schmidt, 2001, Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile, Eur J Pharmacol, 425, 197, 10.1016/S0014-2999(01)01188-8 · DOI · Paper page
- Shapiro, 1989, Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
- Vervaet, 1993, Reproducibility of QTc-measurements in healthy volunteers, Acta Cardiol, 48, 555
- Wilens, 1996, Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents, J Am Acad Child Adolesc Psychiatry, 35, 1491, 10.1097/00004583-199611000-00018 · DOI · Paper page
Cited by
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX · doi:10.1016/j.nurx.2006.01.009 · Cited by 300
Self-citationPractice Parameter for the Assessment and Treatment of Children and Adolescents With Tic Disorders
Murphy, T. K., Lewin, A. B., Storch, E. A., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.015 · Cited by 276
Antipsychotic Use in Children and Adolescents: Minimizing Adverse Effects to Maximize Outcomes
CORRELL, C. U. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815b5cb1 · Cited by 254
Metadata
- Authors
- BLAIR, J., SCAHILL, L., STATE, M., & MARTIN, A.
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-01
- Volume
- 44
- Issue
- 1
- Pages
- 73-79
- ISSN
- 0890-8567
- Cited by
- 93
- References
- 3
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study. https://app.cochat.ai/papers/10.1097/01.chi.0000145372.61239.bb
- The paper
- BLAIR, J., SCAHILL, L., STATE, M., & MARTIN, A. (2005). Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective Study. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/01.chi.0000145372.61239.bb
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.